Immune-based IVD for cancer and neurology
Immune-based In Vitro Diagnostics for cancer and neurology early detection.
Our mission is to be the leader in Immuno-Diagnostic space focused on the development of blood-based tests for the early detection of cancers and neurodegenerative (ND) diseases.
A patented technology for Breast cancer screening (TM-B1, TM-B2), Colon cancer screening (TM-C1) and potential other cancers.
“Total Biochemical Infrared Analysis” (TBIA) Technology is a proprietary method for screening of solid tumors using peripheral blood spectroscopy and advanced machine learning analysis.
It is a new approach for observing the immune system’s response to tumor presence rather than looking for the tumor cells themselves or specific markers. TBIA analyzes the entire biochemical signatures spectrum (including proteins, lipids, nucleic acids and carbohydrates) of effected immune cells and plasma from peripheral blood.
A test for Alzheimer’s disease (possibly additional ND diseases)
“Lymphocyte Proliferation test” (LymPro Test) measures immune markers that are directly linked to well establish cell proliferation processes.
The LymPro test is a validated blood-based lymphocyte assay that can assist research professionals in differentiating between non-AD subjects and those with prodromal AD, mild cognitive impairment (MCI) due to AD or dementia due to AD.